Home Law \ Legal Freshfields advises Evotec on acquisition of Central Glass Germany

Freshfields advises Evotec on acquisition of Central Glass Germany

2 min read
Comments Off on Freshfields advises Evotec on acquisition of Central Glass Germany
0
56


Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) is advising publicly listed Evotec SE on the acquisition of Central Glass Germany GmbH from Japanese chemical manufacturing company Central Glass Co. Ltd.

Central Glass Germany is an EU GMP certified contract developer and manufacturer (CDMO) of active pharmaceutical ingredients with a drug substance manufacturing facility in Halle (Westphalia). Evotec SE is a life science company researching, developing and manufacturing highly effective therapeutics and is listed on the TecDAX and MDAX as well as on NASDAQ.

Freshfields is advising Evotec SE on the corporate and tax structuring of the transaction and negotiation of the share purchase agreement as well as on the negotiation of a new long-term lease agreement for the production facility.

The cross-practice Freshfields team was led by Partner Christoph H. Seibt (Lead) and Principal Associate Jil Rollmann (both Global Transactions, Hamburg) and included i.a.:

  • Partner: Niko Schultz-Süchting (Real Estate, Hamburg), Alexander Schwahn (Tax, Hamburg)
  • Counsel: Sascha Arnold (Regulatory, Hamburg)
  • Principal Associates: Aljosha Barath (Intellectual Property, Hamburg), Tobias Franz (Tax, Hamburg)
  • Associates: Vasco Ollero (Global Transactions, Hamburg), Daniel Extra (Real Estate, Hamburg), Jan Kothe (Tax, Hamburg)

Evotec SE is advised inhouse by General Counsel Christian Dargel.





Source link

Load More Related Articles
Load More By James Tisdale
Load More In Law \ Legal
Comments are closed.

Check Also

OPEC+ supply cut essential to buoy oil prices, UBS says

An oil production cut by the Organization of the Petroleum Exporting Countries and allies …